Christopher Leach has joined Kirkland & Ellis as a partner in their FTC consumer protection group.
Christopher Leach is a litigation partner in Kirkland’s Washington, D.C., office. As a former attorney with the US Federal Trade Commission (FTC), his practice focuses on consumer-facing issues, including data privacy, false advertising, marketing practices and other aspects of customer acquisition. He represents and advises clients in a broad range of industries, including the fintech, financial services, food and beverage, automotive and telecommunications industries, defending those companies in litigation, before government agencies and in self-regulatory proceedings such as the National Advertising Division (NAD).
As a lawyer in the FTC’s Division of Financial Practices, Christopher investigated and litigated consumer protection enforcement actions and developed enforcement policy. His relevant areas of experience include fintech, cryptocurrency, consumer financial data privacy, gig economy, fair lending and consumer telecommunications. He worked on some of the agency’s most visible fintech actions, including active litigation against FleetCor Technologies, Inc. and its CEO for deceptive advertising and charging customers hundreds of millions of dollars in unauthorized fees through its B2B payment system; a $10 million settlement with Yellowstone Capital in connection with the company’s merchant-cash-advance practices; and advised on cryptocurrency issues.
Source: Kirkland
Featured News
Justice Department Moves to End NCAA Transfer Rule
May 30, 2024 by
CPI
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI